Daraxonrasib for Previously Treated <i>RAS</i> -Mutant Non–Small-Cell Lung Cancer

Kathryn C. Arbour, Salman Punekar, Jia Luo, Melissa Johnson, Alexander Spira, Benjamin Herzberg, Alexander Starodub, David Sommerhalder, Joel Randolph Hecht, Ignacio Garrido-Laguna, Minal Barve, Sai-Hong Ignatius Ou, Sumit Kar, Lei Bao, Lin Tao, Rashmi Vora, Aparna Hegde, Andreas Saltos, Nilofer S. Azad, David S. Hong

Open source

DOI: 10.1056/nejmoa2504059
Published: 2026-09-03
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2504059,
  title = {Daraxonrasib for Previously Treated
                    <i>RAS</i>
                    -Mutant Non–Small-Cell Lung Cancer},
  author = {Kathryn C. Arbour and Salman Punekar and Jia Luo and Melissa Johnson and Alexander Spira and Benjamin Herzberg and Alexander Starodub and David Sommerhalder and Joel Randolph Hecht and Ignacio Garrido-Laguna and Minal Barve and Sai-Hong Ignatius Ou and Sumit Kar and Lei Bao and Lin Tao and Rashmi Vora and Aparna Hegde and Andreas Saltos and Nilofer S. Azad and David S. Hong},
  year = {2026},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa2504059},
  url = {https://doi.org/10.1056/nejmoa2504059}
}

RIS

TY  - JOUR
TI  - Daraxonrasib for Previously Treated
                    <i>RAS</i>
                    -Mutant Non–Small-Cell Lung Cancer
AU  - Kathryn C. Arbour
AU  - Salman Punekar
AU  - Jia Luo
AU  - Melissa Johnson
AU  - Alexander Spira
AU  - Benjamin Herzberg
AU  - Alexander Starodub
AU  - David Sommerhalder
AU  - Joel Randolph Hecht
AU  - Ignacio Garrido-Laguna
AU  - Minal Barve
AU  - Sai-Hong Ignatius Ou
AU  - Sumit Kar
AU  - Lei Bao
AU  - Lin Tao
AU  - Rashmi Vora
AU  - Aparna Hegde
AU  - Andreas Saltos
AU  - Nilofer S. Azad
AU  - David S. Hong
PY  - 2026
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2504059
UR  - https://doi.org/10.1056/nejmoa2504059
ER  -

APA

Arbour, K. C., Punekar, S., Luo, J., Johnson, M., Spira, A., Herzberg, B., Starodub, A., Sommerhalder, D., Hecht, J. R., Garrido-Laguna, I., Barve, M., Ou, S. I., Kar, S., Bao, L., Tao, L., Vora, R., Hegde, A., Saltos, A., Azad, N. S., & Hong, D. S. (2026). Daraxonrasib for Previously Treated <i>RAS</i> -Mutant Non–Small-Cell Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2504059

Source records

crossref · retrieved 2026-09-26T03:40:38.390Z